Pulmonary static inflation with 50% xenon attenuates decline in tissue factor in patients undergoing Stanford type A acute aortic dissection repair
The Stanford type A acute aortic dissection (AAD) carries a high risk of mortality and morbidity, and patients undergoing AAD surgery often bleed excessively and require blood products and transfusions. Thus, we studied how xenon alters coagulation using thromboelastography (TEG) and conventional he...
Saved in:
Published in | Journal of thoracic disease Vol. 10; no. 7; pp. 4368 - 4376 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
China
AME Publishing Company
01.07.2018
|
Subjects | |
Online Access | Get full text |
ISSN | 2072-1439 2077-6624 |
DOI | 10.21037/jtd.2018.06.95 |
Cover
Abstract | The Stanford type A acute aortic dissection (AAD) carries a high risk of mortality and morbidity, and patients undergoing AAD surgery often bleed excessively and require blood products and transfusions. Thus, we studied how xenon alters coagulation using thromboelastography (TEG) and conventional hemostatic tests for patients with AAD undergoing aortic arch surgery involving cardiopulmonary bypass (CPB)/deep hypothermic circulatory arrest (DHCA).
This prospective single-center nonrandomized controlled clinical trial, registered in the Chinese Clinical Trial Registry (ChiCTR-ICR-15006435), assessed perioperative clinical variables and serological results from 50 subjects undergoing pulmonary static inflation with 50% nitrogen/50% oxygen from January 2013 to January 2014 and 50 subjects undergoing pulmonary static inflation with 50% xenon/50% oxygen from January 2014 to December 2014 during CPB for Stanford type A AAD. Repeated measures ANOVA were used to identify the effects of xenon on coagulation after surgery. The primary endpoint was perioperative changes in coagulation and fibrinolysis after intubation and 10 minutes, and 6 hours after the operation. The secondary endpoint was to assess the perioperative changes in serum level of tissue factor (TF), tissue factor pathway inhibitor (TFPI) and tissue plasminogen activator (tPA) after intubation and 10 minutes, and 6 hours after the operation.
Mean prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), median fibrinogen degradation product (FDP), and D-dimer peaked and then decreased over 6 hours after surgery. TEG followed a similar trend. From the start to the end of surgery and until 6 h after surgery, mean TF decreased in controls (β -2.61, P<0.001 and β -2.83, P<0.001, respectively), but was maintained relatively stable in xenon group (β -0.5, P<0.001 and β -0.96, P<0.001, respectively).
Deterioration of coagulation function and activated fibrinolysis was confirmed by conventional tests and TEG analysis after Stanford type A AAD repair. Pulmonary static inflation with 50% xenon attenuates decline in TF in patients undergoing Stanford type A AAD repair. |
---|---|
AbstractList | The Stanford type A acute aortic dissection (AAD) carries a high risk of mortality and morbidity, and patients undergoing AAD surgery often bleed excessively and require blood products and transfusions. Thus, we studied how xenon alters coagulation using thromboelastography (TEG) and conventional hemostatic tests for patients with AAD undergoing aortic arch surgery involving cardiopulmonary bypass (CPB)/deep hypothermic circulatory arrest (DHCA).BACKGROUNDThe Stanford type A acute aortic dissection (AAD) carries a high risk of mortality and morbidity, and patients undergoing AAD surgery often bleed excessively and require blood products and transfusions. Thus, we studied how xenon alters coagulation using thromboelastography (TEG) and conventional hemostatic tests for patients with AAD undergoing aortic arch surgery involving cardiopulmonary bypass (CPB)/deep hypothermic circulatory arrest (DHCA).This prospective single-center nonrandomized controlled clinical trial, registered in the Chinese Clinical Trial Registry (ChiCTR-ICR-15006435), assessed perioperative clinical variables and serological results from 50 subjects undergoing pulmonary static inflation with 50% nitrogen/50% oxygen from January 2013 to January 2014 and 50 subjects undergoing pulmonary static inflation with 50% xenon/50% oxygen from January 2014 to December 2014 during CPB for Stanford type A AAD. Repeated measures ANOVA were used to identify the effects of xenon on coagulation after surgery. The primary endpoint was perioperative changes in coagulation and fibrinolysis after intubation and 10 minutes, and 6 hours after the operation. The secondary endpoint was to assess the perioperative changes in serum level of tissue factor (TF), tissue factor pathway inhibitor (TFPI) and tissue plasminogen activator (tPA) after intubation and 10 minutes, and 6 hours after the operation.METHODSThis prospective single-center nonrandomized controlled clinical trial, registered in the Chinese Clinical Trial Registry (ChiCTR-ICR-15006435), assessed perioperative clinical variables and serological results from 50 subjects undergoing pulmonary static inflation with 50% nitrogen/50% oxygen from January 2013 to January 2014 and 50 subjects undergoing pulmonary static inflation with 50% xenon/50% oxygen from January 2014 to December 2014 during CPB for Stanford type A AAD. Repeated measures ANOVA were used to identify the effects of xenon on coagulation after surgery. The primary endpoint was perioperative changes in coagulation and fibrinolysis after intubation and 10 minutes, and 6 hours after the operation. The secondary endpoint was to assess the perioperative changes in serum level of tissue factor (TF), tissue factor pathway inhibitor (TFPI) and tissue plasminogen activator (tPA) after intubation and 10 minutes, and 6 hours after the operation.Mean prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), median fibrinogen degradation product (FDP), and D-dimer peaked and then decreased over 6 hours after surgery. TEG followed a similar trend. From the start to the end of surgery and until 6 h after surgery, mean TF decreased in controls (β -2.61, P<0.001 and β -2.83, P<0.001, respectively), but was maintained relatively stable in xenon group (β -0.5, P<0.001 and β -0.96, P<0.001, respectively).RESULTSMean prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), median fibrinogen degradation product (FDP), and D-dimer peaked and then decreased over 6 hours after surgery. TEG followed a similar trend. From the start to the end of surgery and until 6 h after surgery, mean TF decreased in controls (β -2.61, P<0.001 and β -2.83, P<0.001, respectively), but was maintained relatively stable in xenon group (β -0.5, P<0.001 and β -0.96, P<0.001, respectively).Deterioration of coagulation function and activated fibrinolysis was confirmed by conventional tests and TEG analysis after Stanford type A AAD repair. Pulmonary static inflation with 50% xenon attenuates decline in TF in patients undergoing Stanford type A AAD repair.CONCLUSIONSDeterioration of coagulation function and activated fibrinolysis was confirmed by conventional tests and TEG analysis after Stanford type A AAD repair. Pulmonary static inflation with 50% xenon attenuates decline in TF in patients undergoing Stanford type A AAD repair. The Stanford type A acute aortic dissection (AAD) carries a high risk of mortality and morbidity, and patients undergoing AAD surgery often bleed excessively and require blood products and transfusions. Thus, we studied how xenon alters coagulation using thromboelastography (TEG) and conventional hemostatic tests for patients with AAD undergoing aortic arch surgery involving cardiopulmonary bypass (CPB)/deep hypothermic circulatory arrest (DHCA). This prospective single-center nonrandomized controlled clinical trial, registered in the Chinese Clinical Trial Registry (ChiCTR-ICR-15006435), assessed perioperative clinical variables and serological results from 50 subjects undergoing pulmonary static inflation with 50% nitrogen/50% oxygen from January 2013 to January 2014 and 50 subjects undergoing pulmonary static inflation with 50% xenon/50% oxygen from January 2014 to December 2014 during CPB for Stanford type A AAD. Repeated measures ANOVA were used to identify the effects of xenon on coagulation after surgery. The primary endpoint was perioperative changes in coagulation and fibrinolysis after intubation and 10 minutes, and 6 hours after the operation. The secondary endpoint was to assess the perioperative changes in serum level of tissue factor (TF), tissue factor pathway inhibitor (TFPI) and tissue plasminogen activator (tPA) after intubation and 10 minutes, and 6 hours after the operation. Mean prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), median fibrinogen degradation product (FDP), and D-dimer peaked and then decreased over 6 hours after surgery. TEG followed a similar trend. From the start to the end of surgery and until 6 h after surgery, mean TF decreased in controls (β -2.61, P<0.001 and β -2.83, P<0.001, respectively), but was maintained relatively stable in xenon group (β -0.5, P<0.001 and β -0.96, P<0.001, respectively). Deterioration of coagulation function and activated fibrinolysis was confirmed by conventional tests and TEG analysis after Stanford type A AAD repair. Pulmonary static inflation with 50% xenon attenuates decline in TF in patients undergoing Stanford type A AAD repair. |
Author | Pan, Xudong Cheng, Weiping Yang, Yanwei Lu, Jiakai Zhu, Junming Jin, Mu |
Author_xml | – sequence: 1 givenname: Xudong surname: Pan fullname: Pan, Xudong – sequence: 2 givenname: Jiakai surname: Lu fullname: Lu, Jiakai – sequence: 3 givenname: Weiping surname: Cheng fullname: Cheng, Weiping – sequence: 4 givenname: Yanwei surname: Yang fullname: Yang, Yanwei – sequence: 5 givenname: Junming surname: Zhu fullname: Zhu, Junming – sequence: 6 givenname: Mu surname: Jin fullname: Jin, Mu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30174885$$D View this record in MEDLINE/PubMed |
BookMark | eNp1UUtLHTEUDsVS7a3r7iQboZu55jWPbASRvkBooboOmeTMNTI3GZOMrb-jf7iZq5VWMJsczvkeh_O9RXs-eEDoPSVrRglvT26yXTNCuzVp1rJ-hQ4YaduqaZjY29WsooLLfXSY0g0pryGMte0btM8JbUXX1Qfo9_d53Aav4z1OWWdnsPPDWIrg8U-Xr3FNjvEvKM5Y5wx-1hkStmBG56FgcXYpzYAHbXKIS2MqZPA54dlbiJvg_Ab_yNoPIVqc7yfAZ1ibOQPWIS6GtiiA2TlGmLSL79DrQY8JDh__Fbr69PHy_Et18e3z1_Ozi8pwyXMlNCHUMk2MYJoBY5JT6KytGyYHJqHvOymE0Y3oSl9I27ZsEB3nuofe1JSv0OmD7jT3W7CmbB31qKbotuUeKmin_p94d6024U41tJyyJLBCHx4FYridIWW1dcnAOGoPYU6KESmJoJws0KN_vZ5M_iZRACcPABNDShGGJwglahe3KnGrJW5FGiUXRv2MYVzeJVeWdeOLvD_QGbKk |
CitedBy_id | crossref_primary_10_3389_fcvm_2023_1109620 crossref_primary_10_1186_s13019_020_01383_w crossref_primary_10_1186_s13019_020_01296_8 crossref_primary_10_1186_s13063_024_08290_8 |
ContentType | Journal Article |
Copyright | 2018 Journal of Thoracic Disease. All rights reserved. 2018 Journal of Thoracic Disease. |
Copyright_xml | – notice: 2018 Journal of Thoracic Disease. All rights reserved. 2018 Journal of Thoracic Disease. |
DBID | AAYXX CITATION NPM 7X8 5PM |
DOI | 10.21037/jtd.2018.06.95 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2077-6624 |
EndPage | 4376 |
ExternalDocumentID | PMC6106010 30174885 10_21037_jtd_2018_06_95 |
Genre | Journal Article |
GroupedDBID | 53G AAKDD AAWTL AAYXX ACGFO ADBBV AENEX AIAGR ALMA_UNASSIGNED_HOLDINGS BAWUL BMSDO CITATION DIK GX1 HYE OK1 RPM 04C M~E NPM 7X8 5PM |
ID | FETCH-LOGICAL-c393t-4a001d2a0c42a2e22931e8dd5629f29ebb8944ca6481e849d772f4833abebc513 |
ISSN | 2072-1439 |
IngestDate | Thu Aug 21 14:14:08 EDT 2025 Thu Sep 04 23:02:35 EDT 2025 Wed Feb 19 02:43:29 EST 2025 Tue Jul 01 04:37:33 EDT 2025 Thu Apr 24 22:58:41 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | blood coagulation disorders Ruptured aortic aneurysm xenon tissue factor (TF) |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c393t-4a001d2a0c42a2e22931e8dd5629f29ebb8944ca6481e849d772f4833abebc513 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Contributions: (I) Conception and design: X Pan, J Lu, W Cheng, J Zhu, M Jin; (II) Administrative support: None; (III) Provision of study materials or patients: J Zhu, M Jin; (IV) Collection and assembly of data: X Pan, Y Yang; (V) Data analysis and interpretation: X Pan, J Lu, W Cheng, J Zhu, M Jin; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. These authors contributed equally to this work. |
OpenAccessLink | https://jtd.amegroups.com/article/viewFile/22270/pdf |
PMID | 30174885 |
PQID | 2099041300 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6106010 proquest_miscellaneous_2099041300 pubmed_primary_30174885 crossref_primary_10_21037_jtd_2018_06_95 crossref_citationtrail_10_21037_jtd_2018_06_95 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-7-00 2018-Jul 20180701 |
PublicationDateYYYYMMDD | 2018-07-01 |
PublicationDate_xml | – month: 07 year: 2018 text: 2018-7-00 |
PublicationDecade | 2010 |
PublicationPlace | China |
PublicationPlace_xml | – name: China |
PublicationTitle | Journal of thoracic disease |
PublicationTitleAlternate | J Thorac Dis |
PublicationYear | 2018 |
Publisher | AME Publishing Company |
Publisher_xml | – name: AME Publishing Company |
SSID | ssj0000602277 |
Score | 2.1472454 |
Snippet | The Stanford type A acute aortic dissection (AAD) carries a high risk of mortality and morbidity, and patients undergoing AAD surgery often bleed excessively... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 4368 |
SubjectTerms | Original |
Title | Pulmonary static inflation with 50% xenon attenuates decline in tissue factor in patients undergoing Stanford type A acute aortic dissection repair |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30174885 https://www.proquest.com/docview/2099041300 https://pubmed.ncbi.nlm.nih.gov/PMC6106010 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFA7jCuLL4t1ZL0RQEIaumfT-OIiyCCv7sIvjU0mTjFtdZmS2RfFv-If8aZ6T06ad0YHVl86QpunlfD3nS3oujD0HpV_aTC2C2KRRgMGP8EplIjBSWhVp2G0wwPn4fXJ0Fr2bx_PR6NfAa6mpy0P9469xJf8jVWgDuWKU7D9I1g8KDfAf5AtbkDBsryTjk-YCzoV-bxgXVGl0rSLfNlpfjcULGU--2yW6HNfAjhtklhNjtSOX6OLonntbdWfS51m9dPVx159WlLBbLV1YoVuvnU2URucCtcILmrgP-lRvfA2mrVrvoLv1OYBN0wHDT0IntAI7b8yqNaLoHtQ4dFXqi6p6BwRLeumDxXrbvu_HdsUbfr_ZariKMc28x2ur7KRIZQDcjdSn7drSIEkoxtprazFAZTpQvZhKf2DGo5DqymybCNlmGfhcY57YqcveSmU-N5NxbxlJ77oIkyY3RAEDFDhAIZIij6-x6zJNnaNAt15EXABTNGLMvr9Byi_lxni1eRGb1OiP-c622-6AB53eYvutRPmM0HibjezyDrtx3Lpo3GU_PSg5gZJ7UHIEJQdQcgdJ3kOSt5CEvpwgyQmS2NBBkveQ5B0kOUKSz7iDJCdI8h6SnCB5j529fXP6-ihoK38EOszDOogUsCcjlQBloaSVwEmnNjMGyHq-kLktyyyPIq2SKIP2KDcwR1xEWRiq0pY6nob32R7ch33IeCoMMPRFbEus_JCaTJRayVDHCxHHMgnH7LB76IVu0-JjdZaLYoekx-ylP-ArZYTZ3fVZJ8UCtDZ-ilNLu2ouCwxYF8gfxZg9IKn6wcDkpmBW4eh0Q96-A2aE39yzrM5dZniYC-ECy8HVL_ERu9m_jo_ZXr1u7BOg2XX51CH5N_nz2Dk |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pulmonary+static+inflation+with+50%25+xenon+attenuates+decline+in+tissue+factor+in+patients+undergoing+Stanford+type+A+acute+aortic+dissection+repair&rft.jtitle=Journal+of+thoracic+disease&rft.au=Pan%2C+Xudong&rft.au=Lu%2C+Jiakai&rft.au=Cheng%2C+Weiping&rft.au=Yang%2C+Yanwei&rft.date=2018-07-01&rft.issn=2072-1439&rft.eissn=2077-6624&rft.volume=10&rft.issue=7&rft.spage=4368&rft.epage=4376&rft_id=info:doi/10.21037%2Fjtd.2018.06.95&rft.externalDBID=n%2Fa&rft.externalDocID=10_21037_jtd_2018_06_95 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-1439&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-1439&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-1439&client=summon |